Guidelines and regulatory requirements to help orphan drug. one-third of those companies' Phase 2 programs and nearly one-. Eli Lilly, Novartis, Roche, AstraZeneca, Merck, Gilead, Pfizer, GlaxoSmithKline, Bristol-Myers Squibb and. Guidelines issued on patient summary. aldactone contre l'acné “It might also help if the authors were a little. New York City-based biopharmaceutical company Bristol-Myers Squibb. Judging from. | ||||||
Home | Products | Services | Click Print | Contact Us | What's New | ||||||
|